Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Internet Marketing > What Most Becomes a Conversation

Tags

  • involved
  • another
  • market
  • combination products
  • companies involved

  • Links

  • How to Pick Up a Girl - Rapport Techniques
  • Getaway to Sophisticated Toronto This Weekend!
  • Simply Effective Sales Tips
  • Just Other Articles - What Most Becomes a Conversation

    Lately, I have been noticing a lot more talk about “enabling conversations” with the use of various communications tools such as blogs, podcasts and the like. L
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    et me take a moment to dissect this trendlet and give you my thoughts. Back in the day, we used the phone to have conversations when we weren’t physically in t
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e same place. Few of us have that luxury anymore. So what would you consider second best – maybe an email exchange? But we all get too many emails, and besides,
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    it might go into my spam bucket for some reason, so you can’t be sure that I will get your message. This is especially true when I send out my Web Informant, no
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    t that there is anything wrong with sending it out.

    It is just that a lot of newsletters get caught by the filters and trashed, so you can never be sure that s
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    meone actually got them. Another issue with newsletters is that they are one way. Sure a lot of readers will respond and I enjoy your responses, but then the o
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    hers don’t get to read these responses. I can post these to another newsletter (and sometimes I have in the past), but that still is a cumbersome process and fa
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    r from the natural conversation of a phone call. Another choice is Instant Messaging. I have taken to using IM for those critical conversations where I need to
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    locate a source or a PR person Right Now, and that works relatively well — for those people that I have their IM address, and are available during the day, or a
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    least deem to say to me that they are available.

    Perhaps better than IM is the blog. Our readers can post at will, or at least, when we approve the postings t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    weed out comment spam. But not every reader is going to take the time to read our blogs every day/week/month. That is where RSS was invented, to alert people w
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    hen new comments or content arrives. But many PR people still don’t know what RSS is or how to use it. Shameless plug: I am giving a talk next week in Vegas on
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    his very subject at the New Communications Forum, you can find the information on the conference here:. http://www.newcommforum.com/

    Then how about podcasts?
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ome podcasts are recordings of actual conversations between two or more people — and some of the best ones like Steve Gibson’s Security Now podcasts are just th
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    at, him and Leo Laporte just talking for 45 minutes or so. Is this “better” than reading comments in a blog? It could be — and in the particular case of Gibson,
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    you can learn a lot about security tech in those 45 minutes, and much better use of your time (especially if you listen while driving or flying) than reading a
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ranscript or an article.

    And finally we have video blogs, where you would think this would be the height of conversation since we are talking to a camera, not
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    just recording audio. But to make an engaging video isn’t as easy as it seems, and I’d rather watch those pirated Colbert/Stewart clips than some of the things
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    hat I have seen posted on You Tube. Plus, finding the more relevant ones isn’t easy either. So many of us have gone full circle on this conversation thing and
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    re back to just calling people on the phone — perhaps first after IMing them to make sure that they are actually available. Gee, isn’t this tech stuff wonderful


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/64594/justotherarticles-What-Most-Becomes-a-Conversation.html">What Most Becomes a Conversation</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/64594/justotherarticles-What-Most-Becomes-a-Conversation.html]What Most Becomes a Conversation[/url]

    Related Articles:

    What Should Your Business Card Say?

    Ecommerce: I Second That Emotional Connection

    To Get Your Email To Stand Out From All The Junk

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com